• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bristol-Myers Squibb (NY: BMY )

    43.90 -0.09 (-0.20%)
    Official Closing Price Updated: 4:10 PM EDT, May 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,119,662
    Open 44.16
    Bid (Size) 43.89 (2)
    Ask (Size) 43.90 (1)
    Prev. Close 43.99
    Today's Range 43.78 - 44.62
    52wk Range 43.33 - 69.10
    Shares Outstanding 2,222,113,553
    Dividend Yield 5.19%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
    Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time. 
    Via InvestorPlace
    U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
    From Bristol Myers Squibb
    Via Business Wire

    Performance

    YTD
    -16.79%
    -16.79%
    1 Month
    -14.46%
    -14.46%
    3 Month
    -8.50%
    -8.50%
    6 Month
    -16.84%
    -16.84%
    1 Year
    -35.83%
    -35.83%

    More News

    Read More
    European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
    From Bristol Myers Squibb
    Via Business Wire
    A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
    Via Benzinga
    How Is The Market Feeling About Bristol-Myers Squibb?
    Via Benzinga
    Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Uncover the Potential: 3 Discounted Stocks Ready for a Comeback
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
    Via The Motley Fool
    If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
    Via The Motley Fool
    Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
    From Editas Medicine, Inc.
    Via GlobeNewswire
    Why Bristol Myers Squibb Stock Is Sinking Today
    Via The Motley Fool
    3 Top ETFs to Buy for Passive Income in May
    Via The Motley Fool
    Topics ETFs
    Last Week's Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
    Via Benzinga
    Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights
    Via Benzinga
    Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
    Via Investor's Business Daily
    CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
    From Bristol Myers Squibb
    Via Business Wire
    Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
    Via Benzinga
    Exposures Fossil Fuels
    Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
    Via Benzinga
    PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.